Global Cord Blood Corporation

OTCPK:CORB.F Stock Report

Market Cap: US$140.6m

Global Cord Blood Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Tina Zheng

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure15.9yrs
CEO ownershipn/a
Management average tenure15.9yrs
Board average tenure2.5yrs

Recent management updates

Recent updates

Global Cord Blood GAAP EPS of $0.14, revenue of $46.88M

Jul 05

Pounce On Global Cord For The Year Of The Tiger

Apr 29

Global Cord Blood Corp. Looks Anemic On Slow Growth, Regulatory Concerns

Apr 08

Global Cord Blood: With 6.0x P/E And 24% EPS CAGR, Subscriber Growth Continues

Dec 01

Global Cord Blood Is An Undervalued Business With Accelerating Growth, Benefiting From China's Policy Changes

Jul 30

Global Cord Blood: New China Policy Catalyst, 146% Net Cash And 24% EPS CAGR

Jul 01

Global Cord Blood announces NHC policy update

Jan 05

Global Cord Blood reports FQ2 results

Nov 24

CEO Compensation Analysis

How has Tina Zheng's remuneration changed compared to Global Cord Blood's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2022n/an/a

CN¥501m

Dec 31 2021n/an/a

CN¥524m

Sep 30 2021n/an/a

CN¥506m

Jun 30 2021n/an/a

CN¥512m

Mar 31 2021CN¥3mCN¥3m

CN¥508m

Dec 31 2020n/an/a

CN¥478m

Sep 30 2020n/an/a

CN¥506m

Jun 30 2020n/an/a

CN¥495m

Mar 31 2020CN¥7mCN¥4m

CN¥471m

Dec 31 2019n/an/a

CN¥465m

Sep 30 2019n/an/a

CN¥381m

Jun 30 2019n/an/a

CN¥326m

Mar 31 2019CN¥3mCN¥3m

CN¥291m

Dec 31 2018n/an/a

CN¥231m

Sep 30 2018n/an/a

CN¥239m

Jun 30 2018n/an/a

CN¥242m

Mar 31 2018CN¥6mCN¥3m

CN¥237m

Compensation vs Market: Insufficient data to establish whether Tina's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Insufficient data to compare Tina's compensation with company performance.

CEO

Tina Zheng (52 yo)

15.9yrs

Tenure

CN¥3,385,565

Compensation

Ms. Ting Zheng, also known as Tina, serves as the Chief Executive Officer of Global Cord Blood Corporation (formerly known as China Cord Blood Corporation) since 2009 and also serves as Chief Executive Off...

Leadership Team

NamePositionTenureCompensationOwnership
Ting Zheng
CEO & CEO of Beijing Division15.9yrsCN¥3.39mno data
Bing Chuen Chen
Chief Financial Officerno dataCN¥3.39mno data
Xin Xu
Chief Technology Officer20.9yrsCN¥804.48kno data
Rui Arashiyama
Chief Executive Officer of Guangdong & Zhejiang Divisions15.9yrsCN¥1.69mno data
Cathy Bai
Vice President of Corporate Financeno datano datano data

15.9yrs

Average Tenure

58.5yo

Average Age

Experienced Management: CORB.F's management team is seasoned and experienced (15.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Ping Xu
Director1.3yrsno datano data
Lingyun Zhai
Director2.5yrsno datano data
Guojun Liu
Director2.5yrsno datano data
Yang Wang
Director2.5yrsno datano data
Shi'an Liu
Director2.5yrsno datano data
Michael Steven Weiss
Director2.5yrsno datano data
Sandipan Bhowmik
Director1.8yrsno datano data
Kai Tse Cheuk
Director1.8yrsno datano data
Nigel Valentino Trayers
Director1.8yrsno datano data

2.5yrs

Average Tenure

Experienced Board: CORB.F's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 09:43
End of Day Share Price 2024/12/20 00:00
Earnings2022/03/31
Annual Earnings2022/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Global Cord Blood Corporation is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Raghuram SelvarajuAegis Capital Corporation
Ye YinBrean Capital
Brian TanquilutJefferies LLC